Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Joseph GTK / Shutterstock.com Advanced Micro Devices (NASDAQ: AMD ) stock is rising higher on Tuesday after announcing a new generation of processors . Let’s go over all the details investors n...
Gainers: Convey Health Solutions CNVY +139%. Valneva VALN +87%. Clovis Oncology (CLVS) +34%. Innate Pharma (IPHA) +28%. Lexaria Bioscience (LEXX) +20%. Losers: ACADIA Pharmaceuticals ACAD -34%. Comera Life Sciences Holdings (CMRA) -17%. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Manuel Esteban / Shutterstock.com Valneva (NASDAQ: VALN ) stock is rocketing higher on Tuesday following news that Pfizer (NYSE: PFE ) is taking a stake in the vaccine company . Pfizer has reach...
The ADRs of Valneva (NASDAQ:VALN) added ~86% in the pre-market Tuesday as the French vaccine maker extended gains following an equity investment from U.S. pharma giant Pfizer (PFE) as part of their collaboration for a vaccine against Lyme Disease. Per the terms, Pfizer (PFE) bo...
Valneva (VALN) (OTCPK:INRLF) rose in the Paris stock exchange on Monday in reaction an agreement under which Pfizer (NYSE:PFE) will purchase 8.1% stake in the French vaccine maker to further support the partnership between the two companies for a vaccine against Lyme Disease. In 2020, Valneva...
Pfizer will invest €90.5 million in Valneva Planned Phase 3 study confirmed to initiate in Q3 2022 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced that they have enter...
Valneva (NASDAQ:VALN -9.8%) entered into a settlement agreement with the Government of the United Kingdom in relation to the termination of the supply agreement for Valneva’s COVID-19 vaccine candidate, VLA2001. Company announced on September 13, 2021 that it had receive...
The ADRs of Valneva SE (NASDAQ:VALN) dropped for the third straight session on Monday after the French vaccine maker said that its deal with European Commission for an experimental COVID-19 shot hangs in the balance. The whole virus, inactivated vaccine candidate, named VLA2001, is designed t...
Valneva (NASDAQ:VALN) said it successfully completed a lot-to-lot phase 3 trial of its single-shot chikungunya vaccine VLA1553. The company said the final analysis included six-month follow-up data and confirmed the results reported in December 2021, where the trial met its main goal. "W...
Several days after experiencing a pleasant share price pop on good regulatory news, Dynavax (NASDAQ: DVAX) repeated the feat on Thursday. An important partner for the company reported an encouraging development that morning, also in the regulatory sphere. Investors lapped up the fre...
News, Short Squeeze, Breakout and More Instantly...
2024-06-25 09:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-03 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-24 20:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...